NRx Pharmaceuticals receives FDA labeling review letter for preservative-free ketamine
NRx Pharmaceuticals announced receipt of an FDA labeling review letter for preservative-free ketamine.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.